CW November 2001Issue Number 11 November 2001 ISSN 10593802 New Anticancer Drugs Based on Inhibition of Signaling ProteinsKnown as oncoproteins, a variety of proteins which cause cancer does so by sending signals to the cell nucleus to divide, multiply and proliferate. A cascade of reactions is involved in this process of signal transduction. Pharmaceutical companies are developing new anticancer drugs ? in fact some of them are in Phase I and II trials ? which will disable the signal transduction in cancer cells, and thus terminate cell proliferation.
Go to Previous Page Go to Next Page Source & Additional Reading A. A. Adjei, Cancer Chemotherapy & Biological Response Modifiers, Annual 19, 149-164, 2001. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW November 2001Purchase Downloadable Full-text PDF of Complete Issue: $10.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |